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 “Development of Structural Neurobiology and Genomics Programs in the Neurogenetic 
Institute” 
Principal Investigator:  Brian E. Henderson, M.D. 
 
The purpose of the DOE equipment-only grant was to purchase instrumentation in 
support of structural biology and genomics core facilities in the Zilkha Neurogenetic 
Institute (ZNI).  The ZNI, a new laboratory facility (125,000 GSF) and a center of 
excellence at the Keck School of Medicine of USC, was opened in 2003.  The goal of the 
ZNI is to recruit upwards of 30 new faculty investigators engaged in interdisciplinary 
research programs that will add breadth and depth to existing school strengths in 
neuroscience, epidemiology and genetics.  For the duration of the grant project period, 
and continuing to the present day, recruitment at the ZNI has been highly successful. Ten 
new neuroscience faculty have joined the ZNI since 2003, with an additional recruit 
joining the faculty by January 1, 2007.  The ZNI will continue to search for quality 
faculty investigators over the next five year period, or until such time as the laboratory 
facility is fully occupied. 
 
A key component to the success of the ZNI recruitment efforts is the availability of 
myriad core laboratory facilities that support various faculty investigators’ research 
programs.  Two such core laboratories are the structural biology and genomics core 
facilities, and for which the DOE provided resources to purchase equipment. 
 
Structural Biology.  The structural biology facility will house equipment necessary to 
determine three-dimensional structure of proteins and nucleic acid and will aid in 
understanding structure-function relationships.  The structural biology group will focus 
on the elucidation of structural and molecular mechanisms in neurodegenerative diseases, 
and in particular, to attempt to uncover the molecular mechanisms by which protein 
deposits form in diseases such as Alzheimer’s and Parkinson’s.  
 
The DOE grant purchased the following equipment in support of the structural biology 
core facility: 
    
Bruker Biospin: Elexsys Spectrometer (partial) 
 
This new technology allows the analysis of spin labeled proteins using pulsed EPR 
spectroscopy.  This technology allows significant improvements over the conventional 
continuous wave EPR spectroscopy.  One of the main improvements is the ability to 
measure long-range distances using DEER or multi quantum coherence 
measurements.  These methodologies extend the sensitivity from 25 Å (conventional 
continuous wave methodology) to 70 Å.  One of the main drawbacks of distance 
measurements using conventional methods has been the fact that only close distances 
could be measured.  Thus, it often required a good first guess to be able to place two 
probes in close proximity.  Many experiments in which probes were not close enough 
have been uninformative. In addition, it has been very difficult to obtain long-range 
distance constraints to refine the structures of multi-domain proteins using conventional 
methods. Another significant new advance lies in the fact that multiple distances can be 
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measured at the same time.  This feature is particularly important in large molecular 
complexes such as the protein aggregates that form in diseases such as Parkinson’s and 
Alzheimer’s disease.  In these diseases, multiple identical subunits come together to form 
toxic assemblies giving rise to multiple distances.  In addition to these applications, the 
use of pulsed EPR has also some more general applications since different relaxation 
times (T1 and T2) can be measured directly. This feature should be useful structural 
analysis of all proteins, but membrane proteins in particular. 
 
Genomics. The genomics facility is being developed to provide large-scale sequencing 
and genotyping for research groups in the ZNI, to other USC research programs, and to 
the broader scientific community.  Scientists throughout USC who are working on 
defining candidate genes of inherited neurological diseases, as well as those who are 
examining regions of natural variation that occur among the genomes of diseased 
compared to non-diseased populations, will continue to utilize this core facility.   
 
The DOE grant purchased the following equipment in support of the genomics core 
facility: 
 
Applied Biosystems: Geneamp PCR System 9700 
Applied Biosystems: DNA Analyzer 
Illumina, Inc.: Beadarray Genotyping System (partial) 
    
This system is a production SNP genotyping system that includes automation equipment 
(including two Tecan Genesis workstations), LIMS, BeadArray Readers, BeadStudio data 
analysis software, hardware and accessories for the generation of millions of genotypes 
per day.  In addition to genotyping, the Illumina BeadLab platform has chemistry 
solutions for the analysis of DNA methylation (96 samples by 1536 sites), gene 
expression profiling (6 samples by ~48,000 genes), and analysis of DNA copy number 
changes and Loss of Heterozygosity (LOH, 1 sample by 550,000 genomic loci). The 
genomics core has been operating near 100% capacity for the past four months with 
interdisciplinary projects planned that will keep the capacity at 100% for at least 1.5 
years.  In the next year we will complete a total of 17 interdisciplinary projects with 
charges totaling over $2M.  In addition, within the last year USC has been awarded three 
federal grants that make extensive use of this core and indeed, may not have been funded 
without the presence and expertise of the genomics facility. 
 
